Granting of options over ordinary shares
EDX Medical Group plc has granted options over ordinary shares to directors and senior management, including Deputy Chairman Martin Walton, Chief Financial Officer Shafia Zahoor, Chief Scientific Officer Professor Sir Christopher Evans, Non-Executive Chairman Jason Holt, and Non-Executive Director Professor Trevor Jones. These options were granted under the company's Non-Enterprise Management Incentive Plan and Enterprise Management Incentive Plan, with a total of 9,750,000 options granted to Mr. Walton, 2,267,500 to Ms. Zahoor, 1,500,000 to Professor Sir Christopher Evans, 1,500,000 to Mr. Holt, and 1,500,000 to Professor Trevor Jones, all with a NIL exercise price and dated April 17, 2026.
Select text to share a quote on X · sign in to keep highlights & notes in your EDX notes
CAMBRIDGE, UK: EDX Medical Group plc ("EDX Medical", the "Company" or the "Group"), which develops innovative digital diagnostic products and services for the personalised treatment for cancer, heart disease and infectious diseases, today announces that it has granted options over ordinary shares in the Company to directors and other members of senior management.
The intention to grant options over ordinary shares in the Company was announced to the market on April 13, 2026, as part of the announcement on the proposed application for admission to trading on AIM and proposed withdrawal of the Company's ordinary shares from AQSE. The details of the proposed share options were contained within that announcement.
Prior to the announcement on April 13, 2026, Mr Martin Walton, Deputy Chairman of the Company, already held options over 3,750,000 ordinary shares in the Company.
The announcement of April 13, 2026, stated the intention for Mr Walton to be granted options over a further 4,214,286 ordinary shares in the Company under the EDX Medical Group plc Non-Enterprise Management Incentive Plan.
The Board has agreed that Mr Walton's previous option over 3,750,000 ordinary shares in the Company should be cancelled and 're-awarded' under the EDX Medical Group plc Non-Enterprise Management Incentive Plan. This means that Mr Walton now holds options over 7,964,286 ordinary shares in the Company under the EDX Medical Group Plc Non-Enterprise Management Incentive Plan. In addition, Mr Walton holds options over 1,785,714 ordinary shares in the Company under the EDX Medical Group plc Enterprise Management Incentive Plan. Mr Walton's total options over ordinary shares in the Company now stands at 9,750,000.
The directors of the Company accept responsibility for the contents of this announcement.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Martin Walton |
| 2 | Reason for the notification | |
| a) | Position/status | Board Director / Deputy Chairman |
| b) | Initial notification /Amendment | Initial notification |
| a) | Name | EDX Medical Group plc |
| b) | LEI | 213800BZVJZTMCZ6DJ63 |
| a) | Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each |
| Identification code | ISIN: GB00BNDMJS47 | |
| b) | Nature of the transaction | Granting of options over ordinary shares under (i) the EDX Medical Group plc Non-Enterprise Management Incentive Plan and (ii) the EDX Medical Group plc Enterprise Management Incentive Plan |
| c) | Price(s) and volume(s) | |
| Price | Volume | |
| (i) NIL | 7,964,286 | |
| (ii) NIL | 1,785,714 | |
| d) | Aggregated information | |
| - Aggregated volume | 9,750,000 | |
| - Price | NIL | |
| e) | Date of the transaction | 2026-04-17 |
| f) | Place of the transaction | XOFF - Outside of a Trading Venue |
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Shafia Zahoor |
| 2 | Reason for the notification | |
| a) | Position/status | Chief Financial Officer |
| b) | Initial notification /Amendment | Initial notification |
| a) | Name | EDX Medical Group plc |
| b) | LEI | 213800BZVJZTMCZ6DJ63 |
| a) | Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each |
| Identification code | ISIN: GB00BNDMJS47 | |
| b) | Nature of the transaction | Granting of options over ordinary shares under (i) the EDX Medical Group plc Non-Enterprise Management Incentive Plan and (ii) the EDX Medical Group plc Enterprise Management Incentive Plan |
| c) | Price(s) and volume(s) | |
| Price | Volume | |
| (i) Nil | 43,214 | |
| (ii) Nil | 2,224,286 | |
| d) | Aggregated information | |
| - Aggregated volume | 2,267,500 | |
| - Price | Nil | |
| e) | Date of the transaction | 2026-04-17 |
| f) | Place of the transaction | XOFF - Outside of a Trading Venue |
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Professor Sir Christopher Evans |
| 2 | Reason for the notification | |
| a) | Position/status | Board Director / Chief Scientific Officer |
| b) | Initial notification /Amendment | Initial notification |
| a) | Name | EDX Medical Group plc |
| b) | LEI | 213800BZVJZTMCZ6DJ63 |
| a) | Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each |
| Identification code | ISIN: GB00BNDMJS47 | |
| b) | Nature of the transaction | Granting of options over ordinary shares under the EDX Medical Group plc Enterprise Management Incentive Plan |
| c) | Price(s) and volume(s) | |
| Price | Volume | |
| Nil | 1,500,000 | |
| d) | Aggregated information | |
| - Aggregated volume | 1,500,000 | |
| - Price | Nil | |
| e) | Date of the transaction | 2026-04-17 |
| f) | Place of the transaction | XOFF - Outside of a Trading Venue |
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Jason Holt |
| 2 | Reason for the notification | |
| a) | Position/status | Board Director / Non-Executive Chairman |
| b) | Initial notification /Amendment | Initial notification |
| a) | Name | EDX Medical Group plc |
| b) | LEI | 213800BZVJZTMCZ6DJ63 |
| a) | Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each |
| Identification code | ISIN: GB00BNDMJS47 | |
| b) | Nature of the transaction | Granting of options over ordinary shares under the EDX Medical Group plc Non-Enterprise Management Incentive Plan |
| c) | Price(s) and volume(s) | |
| Price | Volume | |
| Nil | 1,500,000 | |
| d) | Aggregated information | |
| - Aggregated volume | 1,500,000 | |
| - Price | Nil | |
| e) | Date of the transaction | 2026-04-17 |
| f) | Place of the transaction | XOFF - Outside of a Trading Venue |
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Professor Trevor Jones |
| 2 | Reason for the notification | |
| a) | Position/status | Non-Executive Director |
| b) | Initial notification /Amendment | Initial notification |
| a) | Name | EDX Medical Group plc |
| b) | LEI | 213800BZVJZTMCZ6DJ63 |
| a) | Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each |
| Identification code | ISIN: GB00BNDMJS47 | |
| b) | Nature of the transaction | Granting of options over ordinary shares under the EDX Medical Group plc Non-Enterprise Management Incentive Plan |
| c) | Price(s) and volume(s) | |
| Price | Volume | |
| Nil | 1,500,000 | |
| d) | Aggregated information | |
| - Aggregated volume | 1,500,000 | |
| - Price | Nil | |
| e) | Date of the transaction | 2026-04-17 |
| f) | Place of the transaction | XOFF - Outside of a Trading Venue |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.